Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00281632
What this trial is testing

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Who this might be right for
Peritoneal CancerOvarian CancerNeoplasms, Ovarian+1 more
GlaxoSmithKline 35
Not applicableLooking for participantsNCT06622798
What this trial is testing

Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients

Who this might be right for
Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 470
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Early research (Phase 1)Study completedNCT00816764
What this trial is testing

The Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Who this might be right for
CarcinomaOvarian CancerOvarian Diseases+1 more
Astellas Pharma Inc 18
Testing effectiveness (Phase 2)Looking for participantsNCT07340164
What this trial is testing

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Who this might be right for
Ovarian CancerOvarian Carcinoma, RecurrentOvarian Cancer Metastatic Recurrent+1 more
Yonsei University 116
Not applicableNot Yet RecruitingNCT06558019
What this trial is testing

Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence

Who this might be right for
Ovarian Cancer
Lei Li 509
Testing effectiveness (Phase 2)Looking for participantsNCT07171528
What this trial is testing

Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Cancer Center, Korea 80
Testing effectiveness (Phase 2)Study completedNCT00722592
What this trial is testing

Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)

Who this might be right for
Ovarian Cancer
Endocyte 162
Testing effectiveness (Phase 2)Study completedNCT06266091
What this trial is testing

Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

Who this might be right for
Malignant Ascites
Wuhan YZY Biopharma Co., Ltd. 115
Large-scale testing (Phase 3)Looking for participantsNCT07219238
What this trial is testing

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Who this might be right for
Colorectal CancerGastric CancersOvarian Cancers+1 more
GE Healthcare 175
Testing effectiveness (Phase 2)Study completedNCT00248248
What this trial is testing

DOXIL for Consolidation Therapy in Ovarian Cancer.

Who this might be right for
Ovarian Neoplasm
Southeastern Gynecologic Oncology 45
Testing effectiveness (Phase 2)WithdrawnNCT05736952
What this trial is testing

Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)Ended earlyNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 6
Not applicableLooking for participantsNCT03667417
What this trial is testing

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Who this might be right for
Breast CancersOvarian Cancers
Institut Paoli-Calmettes 5,000
Not applicableStudy completedNCT05132868
What this trial is testing

Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling

Who this might be right for
QualityProstate CancerGastrointestinal Cancer+3 more
Stanford University 78
Early research (Phase 1)Not Yet RecruitingNCT07664735
What this trial is testing

Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

Who this might be right for
Endometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial Cancer+4 more
Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00179725
What this trial is testing

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian Cancer
Celgene Corporation 60
Not applicableWithdrawnNCT02667925
What this trial is testing

Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin

Who this might be right for
Ovarian Cancer
Centre Jean Perrin
Testing effectiveness (Phase 2)UnknownNCT03699449
What this trial is testing

An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer
Yonsei University 104
Next Page